Yeast Beta Glucan Market Regional Outlook, End-User Applicants by 2032

1. Yeast Beta Glucan Market Size to Cross USD 409 Mn by 2032 Global Market Insights Inc.

2. Overview of Yeast Beta Glucan Market • The yeast beta glucan market is expected to reach USD 409 million by 2032, according to a new research report by Global Market Insights Inc. • A food substance that the Food and Drug Administration (FDA) considers safe and is widely used in foods, such as baking foods and beverages, premix, dairy products, cereals, and vegetable protein products. Furthermore, the rising usage of yeast beta glucan in the production of sports nutrition products is increasingly drawing interest from a growing number of health-conscious customers. • The yeast beta glucan market from the insoluble segment is set to grow at CAGR of 10% between 2023 to 2032, due to the increasing use of natural flavoring that is produced using yeast, coupled with prominent initiatives by various companies to launch new products. For instance, in April 2022, AIDP, Inc. stated that Puremune, a branded insoluble yeast beta-glucan by Immudyne Nutritional, received a commercial authorization from Health Canada as a yeast beta glucan source with immunomodulating effects at 30 mg per dosage. Global Market Insights Inc.

3. Continue… • The yeast beta glucan market share from the above 85% segment is set to cross USD 95.5 million in revenue by 2032, attributed to the growing demand for food products with functional benefits among the younger generations, such as millennials, is fueling product use. Furthermore, ongoing initiatives by enterprises to consolidate their business standing are likely to promote segment expansion. In January 2021, Danstar Ferment AG, a Lallemand Inc subsidiary, acquired BiotecBetaGlucans AS (BBG), a producer of high-purity beta glucan, to gain access to promising technologies in yeast-based ingredients. • The from pharmaceutical applications segment is anticipated to depict more than 10.5% CAGR through 2032. In recent years, pharmaceutical companies have amplified their R&D efforts to incorporate the immunity-boosting properties of yeast beta glucan in various treatments, which is expected to impel the market growth. For instance, in August 2022, Ceapro and McMaster University extended an ongoing collaboration to conduct further research on developing an inhalable immuno-therapeutic for treating lung fibrosis caused by the COVID-19 infection with yeast beta glucan that is purified and dried using PGX technology. Global Market Insights Inc.

4. Continue… • The Europe yeast beta glucan market is slated to surpass USD 125 million by 2032. The EU has approved yeast beta-glucan as a novel food component in the manufacturing of beverages and a variety of foods. The rising popularity of health and wellness products, particularly nutritional supplements, has increased the need for yeast beta glucan, which is a major factor likely to boost the regional industry revenue growth. According to NCBI, 72% of adults in Poland use dietary supplements, with 48% consuming them on a regular basis. • Notable participants in the yeast beta glucan market include Kerry Group, Ohly, Mitushi Biopharma, Aria Ingredients, Sanofi, Biorigin, Lallemand, and Leiber. Global Market Insights Inc.

5. Browse Full Research Report On Yeast Beta Glucan Market@ https://bit.ly/43552iw Request for a sample of this research report @ https://bit.ly/43cElsC Global Market Insights Inc.

6. Stay In Touch Website: www.gminsights.com Social Media: Global Market Insights Inc.